Study Name: A Phase 1/1b Study Evaluating the Safety, Tolerability, and Pharmacokinetics of AMG 436 as Monotherapy and in Combination with Other Therapies in Participants with Microsatellite Instability-High (MSI-H)/Mismatch Repair Deficient (dMMR) Solid Tumors